Literature DB >> 17305763

Relationship between intragastric acid control and healing status in the treatment of moderate to severe erosive oesophagitis.

P O Katz1, G G Ginsberg, P E Hoyle, M B Sostek, J T Monyak, D G Silberg.   

Abstract

AIM: To assess the relationship between the percentage of time intragastric pH >4.0 and healing of erosive oesophagitis.
METHODS: In this proof-of-concept study, adults with endoscopically verified Los Angeles grade C or grade D erosive oesophagitis were randomly assigned to oral esomeprazole 10 or 40 mg once daily for 4 weeks. On day 5, patients underwent 24-h pH monitoring. At 4 weeks, erosive oesophagitis healing status was endoscopically assessed. Investigators scored gastro-oesophageal reflux disease symptoms on a 4-point scale [none to severe (0-3)] before and 4 weeks after treatment. The percentage of time intragastric pH was >4.0 and healing status were correlated and tested for significance using a Spearman rank correlation (r).
RESULTS: 103 patients had evaluable data (mean age, 48.7 years; 65% men). Mean percentages of time with intragastric pH >4.0 on day 5 in patients with healed and unhealed erosive oesophagitis were 61% and 42%, respectively (P = 0.0002), indicating that erosive oesophagitis healing rates were positively related to the percentage of time intragastric pH was >4.0. Greater intragastric acid control correlated with lower final daytime and night-time heartburn and acid regurgitation symptom scores (r = -0.029, -0.029 and -0.021; P = 0.003, 0.003 and 0.032, respectively).
CONCLUSION: A positive relationship between intragastric acid control and erosive oesophagitis healing was demonstrated.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17305763     DOI: 10.1111/j.1365-2036.2006.03235.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  13 in total

Review 1.  Proton pump inhibitors: an update of their clinical use and pharmacokinetics.

Authors:  Shaojun Shi; Ulrich Klotz
Journal:  Eur J Clin Pharmacol       Date:  2008-08-05       Impact factor: 2.953

2.  Proton pump inhibitors in the management of GERD.

Authors:  Philip O Katz; Stacey Zavala
Journal:  J Gastrointest Surg       Date:  2009-09-23       Impact factor: 3.452

Review 3.  Histamine2-receptor antagonists: Rapid development of tachyphylaxis with repeat dosing.

Authors:  Johnson W McRorie; James A Kirby; Philip B Miner
Journal:  World J Gastrointest Pharmacol Ther       Date:  2014-05-06

Review 4.  Esomeprazole: a review of its use in the management of gastric acid-related diseases in adults.

Authors:  Kate McKeage; Stephanie K A Blick; Jamie D Croxtall; Katherine A Lyseng-Williamson; Gillian M Keating
Journal:  Drugs       Date:  2008       Impact factor: 9.546

5.  Effect of increasing esomeprazole and pantoprazole doses on acid control in patients with symptoms of gastro-oesophageal reflux disease: a randomized, dose-response study.

Authors:  Clive Wilder-Smith; Anna Backlund; Göran Eckerwall; Tore Lind; Mia Fjellman; Kerstin Röhss
Journal:  Clin Drug Investig       Date:  2008       Impact factor: 2.859

6.  Should peri-gastrectomy gastric acidity be our focus among gastric cancer patients?

Authors:  Lei Huang; A-Man Xu; Tuan-Jie Li; Wen-Xiu Han; Jing Xu
Journal:  World J Gastroenterol       Date:  2014-06-14       Impact factor: 5.742

7.  Comparator pH study to evaluate the single-dose pharmacodynamics of dual delayed-release dexlansoprazole 60 mg and delayed-release esomeprazole 40 mg.

Authors:  Michael Kukulka; Corey Eisenberg; Sai Nudurupati
Journal:  Clin Exp Gastroenterol       Date:  2011-09-14

8.  Relationship between esomeprazole dose and timing to heartburn resolution in selected patients with gastroesophageal reflux disease.

Authors:  Roy C Orlando; Sherry Liu; Marta Illueca
Journal:  Clin Exp Gastroenterol       Date:  2010-09-06

Review 9.  Gastro-esophageal reflux disease in healthy older children and adolescents.

Authors:  Kie Young Park; Soo Hee Chang
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2012-12-31

10.  Pharmacokinetics and Acid Suppressant Efficacy of Esomeprazole after Intravenous, Oral, and Subcutaneous Administration to Healthy Beagle Dogs.

Authors:  J-H Hwang; J-W Jeong; G-H Song; T-S Koo; K-W Seo
Journal:  J Vet Intern Med       Date:  2017-04-13       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.